Cargando…
Angiopoietin-Like4 Is a Novel Marker of COVID-19 Severity
Vascular dysfunction and capillary leak are common in critically ill COVID-19 patients, but identification of endothelial pathways involved in COVID-19 pathogenesis has been limited. Angiopoietin-like 4 (ANGPTL4) is a protein secreted in response to hypoxic and nutrient-poor conditions that has a va...
Autores principales: | Bhatraju, Pavan K., Morrell, Eric D., Stanaway, Ian B., Sathe, Neha A., Srivastava, Avantika, Postelnicu, Radu, Green, Richard, Andrews, Adair, Gonzalez, Martin, Kratochvil, Christopher J., Kumar, Vishakha K., Hsiang, Tien-Ying, Gale, Michael, Anesi, George L., Wyles, David, Broadhurst, M. Jana, Brett-Major, David, Mukherjee, Vikramjit, Sevransky, Jonathan E., Landsittel, Douglas, Hung, Chi, Altemeier, William A., Gharib, Sina A., Uyeki, Timothy M., Cobb, J. Perren, Liebler, Janice M., Crosslin, David R., Jarvik, Gail P., Segal, Leopoldo N., Evans, Laura, Mikacenic, Carmen, Wurfel, Mark M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803343/ https://www.ncbi.nlm.nih.gov/pubmed/36600780 http://dx.doi.org/10.1097/CCE.0000000000000827 |
Ejemplares similares
-
Perceived Hospital Stress, Severe Acute Respiratory Syndrome Coronavirus 2 Activity, and Care Process Temporal Variance During the COVID-19 Pandemic*
por: Anesi, George L., et al.
Publicado: (2023) -
Evaluating construct validity of computable acute respiratory distress syndrome definitions in adults hospitalized with COVID-19: an electronic health records based approach
por: Sathe, Neha A., et al.
Publicado: (2023) -
Reply to Walter and Reyfman: Transcriptomic Analysis of Alveolar Immune Cells in Acute Respiratory Distress Syndrome: To Lump or to Split?
por: Morrell, Eric D., et al.
Publicado: (2019) -
Plasma Soluble CD14 Subtype Levels Are Associated With Clinical Outcomes in Critically Ill Subjects With Coronavirus Disease 2019
por: Mabrey, F. Linzee, et al.
Publicado: (2021) -
Plasma Interleukin-6 Predicts Clinical Decline After Completion of Dexamethasone Therapy in Severe COVID-19
por: Mabrey, F. Linzee, et al.
Publicado: (2022)